Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Intake of tryptophan-enriched whey protein acutely enhances recall of positive loaded words in patients with multiple sclerosis.

Lieben CK, Blokland A, Deutz NE, Jansen W, Han G, Hupperts RM.

Clin Nutr. 2017 Jan 16. pii: S0261-5614(17)30005-5. doi: 10.1016/j.clnu.2016.12.029. [Epub ahead of print]

PMID:
28153503
2.

The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis.

Brandt-Wouters E, Gerlach OH, Hupperts RM.

Int J Gynaecol Obstet. 2016 Aug;134(2):194-6. doi: 10.1016/j.ijgo.2016.01.008. Epub 2016 Apr 18.

PMID:
27177509
3.

Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.

Spelman T, Kalincik T, Jokubaitis V, Zhang A, Pellegrini F, Wiendl H, Belachew S, Hyde R, Verheul F, Lugaresi A, Havrdová E, Horáková D, Grammond P, Duquette P, Prat A, Iuliano G, Terzi M, Izquierdo G, Hupperts RM, Boz C, Pucci E, Giuliani G, Sola P, Spitaleri DL, Lechner-Scott J, Bergamaschi R, Grand'Maison F, Granella F, Kappos L, Trojano M, Butzkueven H.

Neurol Clin Pract. 2016 Apr;6(2):102-115.

4.

Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study.

O'Connor P, Comi G, Freedman MS, Miller AE, Kappos L, Bouchard JP, Lebrun-Frenay C, Mares J, Benamor M, Thangavelu K, Liang J, Truffinet P, Lawson VJ, Wolinsky JS; Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group and the MRI-AC in Houston, Texas.

Neurology. 2016 Mar 8;86(10):920-30. doi: 10.1212/WNL.0000000000002441. Epub 2016 Feb 10. Erratum in: Neurology. 2016 Oct 4;87(14 ):1524.

5.

Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study.

Balak DM, Hengstman GJ, Hajdarbegovic E, van den Brule RJ, Hupperts RM, Thio HB.

BMC Neurol. 2013 Oct 16;13:146. doi: 10.1186/1471-2377-13-146.

6.

Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands.

Karampampa K, Gustavsson A, van Munster ET, Hupperts RM, Sanders EA, Mostert J, Sinnige OL, de Graaf J, Pop P, Miltenburger C, Groot MT, Relleke M, van der Hel WS.

J Med Econ. 2013 Jul;16(7):939-50. doi: 10.3111/13696998.2013.807267. Epub 2013 Jun 12.

PMID:
23692584
7.

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.

Wolinsky JS, Narayana PA, Nelson F, Datta S, O'Connor P, Confavreux C, Comi G, Kappos L, Olsson TP, Truffinet P, Wang L, Miller A, Freedman MS; Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group.

Mult Scler. 2013 Sep;19(10):1310-9. doi: 10.1177/1352458513475723. Epub 2013 Feb 27.

PMID:
23447359
8.

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.

Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA; CARE-MS II investigators.

Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1.

PMID:
23122650
9.

Detection of differential protein expression in cerebrospinal fluid of patients with multiple sclerosis through two-dimensional differential in gel electrophoresis.

Pulinx B, Hupperts RM, Vogt MH, ten Kate J, van Dieijen-Visser MP, Wodzig WK.

Clin Chem Lab Med. 2012;50(9):1693-5. doi: 10.1515/cclm-2012-0011. No abstract available.

PMID:
23089612
10.

Randomized trial of oral teriflunomide for relapsing multiple sclerosis.

O'Connor P, Wolinsky JS, Confavreux C, Comi G, Kappos L, Olsson TP, Benzerdjeb H, Truffinet P, Wang L, Miller A, Freedman MS; TEMSO Trial Group.

N Engl J Med. 2011 Oct 6;365(14):1293-303. doi: 10.1056/NEJMoa1014656.

11.

Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.

Comi G, Cohen JA, Arnold DL, Wynn D, Filippi M; FORTE Study Group.

Ann Neurol. 2011 Jan;69(1):75-82. doi: 10.1002/ana.22316.

PMID:
21280077
12.

Pearls & Oy-sters: electroconvulsive therapy in anti-NMDA receptor encephalitis.

Braakman HM, Moers-Hornikx VM, Arts BM, Hupperts RM, Nicolai J.

Neurology. 2010 Sep 7;75(10):e44-6. doi: 10.1212/WNL.0b013e3181f11dc1. No abstract available.

PMID:
20819992
13.

The contribution of disease severity, depression and negative affectivity to fatigue in multiple sclerosis: a comparison with ulcerative colitis.

Bol Y, Duits AA, Vertommen-Mertens CE, Hupperts RM, Romberg-Camps MJ, Verhey FR, Vlaeyen JW.

J Psychosom Res. 2010 Jul;69(1):43-9. doi: 10.1016/j.jpsychores.2009.11.011. Epub 2010 Jan 21.

PMID:
20630262
14.

The impact of fatigue on cognitive functioning in patients with multiple sclerosis.

Bol Y, Duits AA, Hupperts RM, Verlinden I, Verhey FR.

Clin Rehabil. 2010 Sep;24(9):854-62. doi: 10.1177/0269215510367540. Epub 2010 Jun 24.

PMID:
20576670
15.

Fatigue and physical disability in patients with multiple sclerosis: a structural equation modeling approach.

Bol Y, Duits AA, Lousberg R, Hupperts RM, Lacroix MH, Verhey FR, Vlaeyen JW.

J Behav Med. 2010 Oct;33(5):355-63. doi: 10.1007/s10865-010-9266-8. Epub 2010 May 28.

16.

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.

Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group.

N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20.

17.

The psychology of fatigue in patients with multiple sclerosis: a review.

Bol Y, Duits AA, Hupperts RM, Vlaeyen JW, Verhey FR.

J Psychosom Res. 2009 Jan;66(1):3-11. doi: 10.1016/j.jpsychores.2008.05.003. Epub 2008 Sep 24. Review.

PMID:
19073287
18.

Diagnosis of perimesencephalic nonaneurysmal subarachnoid hemorrhage with computed tomography.

van Dijk EJ, Hupperts RM, van der Jagt M, Bijvoet HW, Hasan D.

J Stroke Cerebrovasc Dis. 2001 Nov-Dec;10(6):247-51.

PMID:
17903834
19.

Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre.

van Oostenbrugge RJ, Hupperts RM, Lodder J.

J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):375-7.

20.

The influence of sex hormones on cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis: a review.

van den Broek HH, Damoiseaux JG, De Baets MH, Hupperts RM.

Mult Scler. 2005 Jun;11(3):349-59. Review.

PMID:
15957520

Supplemental Content

Loading ...
Support Center